Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.
Status unconfirmed · Phase 4
Conditions studied: Arrhythmia, Quality of Life, Hypomagnesemia
In brief
This study is being conducted to see if magnesium can reduce the number of shocks patients with ICDs experience and to see if magnesium supplementation improves patients quality of life.
Key facts
- Study ID
- NCT00282620
- Run by
- Hartford Hospital
- People needed
- 240
- Starts
- 2006-01-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2007-11-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Hartford Hospital — Hartford, Connecticut, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.